The design is Patent Pending and is currently being assessed by the WHO Compendium 2014 secretariat.
Renfrew Group International is developing a Patient Isolation Suit – a sealed environment to be worn by an infectious person which acts to contain microbiological material such as pathogens, spores and viruses. The design is currently being assessed by the WHO Compendium 2014 secretariat
Background to the invention – What is Isolation Technology?
Isolation technology offers enhanced patient handling capabilities yet safely separates the operator from the diseased patient affected with a dangerous virus. For a growing number of such diseases the current facilities in hospitals are no longer believed to be adequate, leading to a shift towards isolation technology to offer the level of protection demanded by current thinking and legislation.
There are a number of isolation systems designed to isolate an infectious or vulnerable person and to prevent the transmission of viruses and other dangerous pathogens to and from the person being treated.
Those at risk are generally health workers, doctors and nursing staff and other orderlies who come into close contact with infectious persons during the discharge of their duties
The current systems range from large installations with negative pressure containment chambers and booths designed to allow health workers to safely tend to the needs of a patient with an infectious condition whilst occupying the same space as the patient. These can be integral to a health facility building or take the form of a temporary structure such as a demountable building or tent.